Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20448
Title: Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.
Austin Authors: Casan, Joshua Ml;Barraclough, Allison ;Shortt, Jake;Hawkes, Eliza A 
Affiliation: School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Haematology Department, Monash Health, Melbourne, Victoria, Australia
Issue Date: Mar-2019
Publication information: The Lancet. Haematology 2019; 6(3): e119
URI: http://ahro.austin.org.au/austinjspui/handle/1/20448
DOI: 10.1016/S2352-3026(19)30013-4
ORCID: 0000-0002-0376-2559
PubMed URL: 30824036
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 30, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.